ClassID:

21570

A61K51/065 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules

Recent Application in this class:
#1
20260124327
2026-05-07

Compounds Targeting Carbonic Anhydrase IX and Uses Thereof

#2
20260061082
2026-03-05

PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED DEEP-TUMOR PENETRATION OF POLYMER NANODRUGS AND METHODS OF USE THEREOF

#3
20250345467
2025-11-13

DENDRIMER FOR THERAPY AND IMAGING

#4
20250340701
2025-11-06

DENDRIMER-DELIVERED ALPHA-PARTICLE RADIOTHERAPY FOR TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS IN THE BRAIN

#5
20250332298
2025-10-30

PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES

#6
20250312498
2025-10-09

PROTOCOL FOR MINIMIZING TOXICITY OF COMBINATION DOSAGES AND IMAGING AGENT FOR VERIFICATION

#7
20250228985
2025-07-17

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#8
20250205371
2025-06-26

HYDROGEL MICROPARTICLES FOR EFFECTIVE RADIOISOTOPE LABELING AND A METHOD FOR THEIR PREPARATION

#9
20250074943
2025-03-06

DLL3 BINDING PEPTIDES AND USES THEREOF

#10
20250049839
2025-02-13

COMPOSITIONS AND METHODS FOR TARGETING CELLS

#11
20250041329
2025-02-06

ACIDIC POLYMER COMPOSITIONS AND METHODS OF USE THEREOF

#12
20250009914
2025-01-09

METHOD FOR SYNTHESIZING HYALURONIC ACID NANOPARTICLES, AND HYALURONIC ACID NANOPARTICLES PREPARED BY METHOD

#13
20240335573
2024-10-10

RADIONUCLIDE MICROSPHERES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#14
20240299597
2024-09-12

3-Iodopropyl-1,2,3-Triazol-1-yl, 3-Bromopropyl-1,2,3-Triazol-1-yl, and Derivatives for Uses in Labeling

#15
20240293588
2024-09-05

THERAPEUTIC CONJUGATES

#16
20240293585
2024-09-05

HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS

#17
20240261447
2024-08-08

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION

#18
20240252695
2024-08-01

RADIOLABELED ETHER DENDRIMER CONJUGATES FOR PET IMAGING AND RADIOTHERAPY

#19
20240207418
2024-06-27

LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME

#20
20240092944
2024-03-21

SYNTHESIS OF UNIFORMLY DEFINED MOLECULAR WEIGHT MANNOSYLATED DEXTRANS AND DERIVATIVES THEREOF

#21
20240082436
2024-03-14

SYNERGISTIC CANCER TREATMENT

#22
20230398241
2023-12-14

RADIOLABELED ETHER DENDRIMER CONJUGATES FOR PET IMAGING AND RADIOTHERAPY

#23
20230381348
2023-11-30

BIFUNCTIONAL MACROCYCLIC CHELATE, CONJUGATE, METAL COMPLEX AND USE THEREOF

#24
20230321286
2023-10-12

PROTOCOL FOR MINIMIZING TOXICITY OF COMBINATION DOSAGES AND IMAGING AGENT FOR VERIFICATION

#25
20230302041
2023-09-28

Competitive Self-Blocking with Unlabeled Manocept Imaging Agents

#26
20230256121
2023-08-17

DOTA-HAPTEN COMPOSITIONS FOR ANTI-DOTA/ANTI-TUMOR ANTIGEN BISPECIFIC ANTIBODY PRETARGETED RADIOIMMUNOTHERAPY

#27
20230218783
2023-07-13

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#28
20230114130
2023-04-13

TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES

#29
20230096064
2023-03-30

Polymeric radiation-sources

#30
20230072421
2023-03-09

TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER

#31
20220409737
2022-12-29

BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS

#32
20220370652
2022-11-24

METHOD FOR PREPARING A RADIONUCLIDE-COATED MICROSPHERE

#33
20220288246
2022-09-15

ADDITIONAL MASS TAG POLYMERS FOR MASS CYTOMETRY

#34
20220267479
2022-08-25

POLYIODIDE BINDING COMPOUNDS AND METHODS OF USE THEREOF

#35
20220249711
2022-08-11

METHODS FOR TREATING TUMORS

#36
20220211884
2022-07-07

RK POLYPEPTIDE RADIOPHARMACEUTICAL TARGETING HER2 AND PREPARATION METHOD THEREOF

#37
20220211680
2022-07-07

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#38
20220152231
2022-05-19

PROCESS OF PREPARING POLYMERIC NANOPARTICLES THAT CHELATE RADIOACTIVE ISOTOPES AND HAVE A SURFACE MODIFIED WITH SPECIFIC MOLECULES TARGETING THE PSMA RECEPTOR AND THEIR USE

#39
20220062448
2022-03-03

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#40
20220054659
2022-02-24

PSMA-TARGETED PAMAM DENDRIMERS FOR SPECIFIC DELIVERY OF IMAGING, CONTRAST AND THERAPEUTIC AGENTS

#41
20220031871
2022-02-03

ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS

#42
20220023448
2022-01-27

DENDRIMER FOR THERAPY AND IMAGING

#43
20220016272
2022-01-20

COMPOSITIONS, METHODS AND KITS FOR DIAGNOSING AND TREATING CD206 EXPRESSING CELL-RELATED DISORDERS

#44
20220010036
2022-01-13

Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof

#45
20210402015
2021-12-30

HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS

#46
20210338848
2021-11-04

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACROPHAGE-RELATED DISORDERS USING CARBOHYDRATE-BASED MACROMOLECULAR CARRIER

#47
20210292438
2021-09-23

CONDITIONAL INTERNALIZATION OF PEGYLATED AGENTS BY PRETARGETING BI-SPECIFIC PEG-BINDING ANTIBODIES FOR DIAGNOSIS AND THERAPY

#48
20210290786
2021-09-23

Composition for radiation treatment of intracavitary or metastatic deposits of malignancy and method for treatment therewith

#49
20210275698
2021-09-09

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#50
20210236668
2021-08-05

COMPOSITIONS FOR RADIOTHERAPY AND USES THEREOF

#51
20210236665
2021-08-05

Bi-dota complex-loaded dendritic polymer nanoparticles

#52
20210145989
2021-05-20

COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS

#53
20210128757
2021-05-06

Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies

#54
20210085809
2021-03-25

ENHANCEMENT OF PATHOGEN IMMUNOGENICITY

#55
20210060188
2021-03-04

TCO conjugates and methods for delivery of therapeutic agents

#56
20210046105
2021-02-18

Compositions and methods for targeting cells

#57
20210002328
2021-01-07

Peptide therapies for reduction of macular thickening

#58
20200397778
2020-12-24

Synergistic cancer treatment

#59
20200360545
2020-11-19

PROTOCOL FOR MINIMIZING TOXICITY OF COMBINATION DOSAGES AND IMAGING AGENT FOR VERIFICATION

#60
20200330613
2020-10-22

SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF

#61
20200254055
2020-08-13

Pharmaceutical compositions and preparations for administration to the eye

#62
20200237938
2020-07-30

Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof

#63
20200237937
2020-07-30

COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY

#64
20200171179
2020-06-04

HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS

#65
20200155714
2020-05-21

DUAL-TARGET IMAGING MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF

#66
20200140572
2020-05-07

CONDITIONAL INTERNALIZATION OF PEGYLATED AGENTS BY PRETARGETING BI-SPECIFIC PEG-BINDING ANTIBODIES FOR DIAGNOSIS AND THERAPY

#67
20200086141
2020-03-19

Polymeric radiation-sources

#68
20200038528
2020-02-06

Radiolabelled material for targeted administration

#69
20200023086
2020-01-23

Bi-DOTA complex-loaded dendritic polymer nanoparticles

#70
20190374661
2019-12-12

Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methods

#71
20190368046
2019-12-05

BODY COMPRISING AN OXIDE OF LANTHANIDE SUPPORTED ON A SULPHUR CONTAINING CARBON BASED PARTICLE AND A METHOD OF PREPARATION THEREOF

#72
20190343916
2019-11-14

Peptides useable for treatment of disorders of the eye

#73
20190309018
2019-10-10

Peptides useable for treating cancer

#74
20190307888
2019-10-10

Polyplex delivery system for proteins, nucleic acids and protein/nucleic acid complexes

#75
20190167803
2019-06-06

TLR9 TARGETED CYTOTOXIC AGENTS

#76
20190142960
2019-05-16

Fucoidan nanogels and methods of their use and manufacture

#77
20190134238
2019-05-09

SN-117M LABELED MANNOSE COUPLED DEXTRAN AMINE

#78
20190111163
2019-04-18

TCO conjugates and methods for delivery of therapeutic agents

#79
20190076557
2019-03-14

HYALURONAN SN-117M COLLOID FOR RADIOSYNOVIORTHESIS AND SYMPTOMATIC THERAPY RELATED APPLICATIONS

#80
20190060490
2019-02-28

PAMAM dendrimer based CEST imaging agents and uses thereof

#81
20190022259
2019-01-24

Use of 99mTc-tilmanocept and related molecular constructs for identifying and diagnosing malignant tumors and for monitoring therapeutic anti-tumor interventions

#82
20190022257
2019-01-24

ULTRAFINE NANOPARTICLES AS AN IMAGING AGENT FOR DIAGNOSING A RENAL DISORDER

#83
20190015530
2019-01-17

Isotope preparation method

#84
20180361000
2018-12-20

DEXTRAN NANOPARTICLES FOR MACROPHAGE SPECIFIC IMAGING AND THERAPY

#85
20180327554
2018-11-15

Biocompatible nanoparticle and use thereof

#86
20180318455
2018-11-08

COMPLEXES BETWEEN BLOCK POLYMERS AND IONS AS CONTRAST AGENTS FOR MEDICAL IMAGING

#87
20180291123
2018-10-11

DI-FUNCTIONALIZED HYALURONIC ACID DERIVATIVES AND HYDROGELS THEREOF

#88
20180264143
2018-09-20

Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof

#89
20180264129
2018-09-20

Core constructs and their uses in configuring pharmaceutical molecules

#90
20180258192
2018-09-13

Therapeutic and imaging compositions and uses thereof

#91
20180250425
2018-09-06

Trifunctional and completely clearable specific targeting agents and methods thereof

#92
20180193410
2018-07-12

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

#93
20180125991
2018-05-10

Oligosaccharide conjugates for targeting bacteria and uses related thereto

#94
20180099048
2018-04-12

Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same

#95
20180055955
2018-03-01

Scandium nano-radiopharmaceutical

#96
20180021462
2018-01-25

Homing agents

#97
20180015187
2018-01-18

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#98
20170333565
2017-11-23

TLR9 TARGETED CYTOTOXIC AGENTS

#99
20170296684
2017-10-19

Radiopharmaceutical conjugate of a metabolite and an EPR agent, for targeting tumour cells

#100
20170209606
2017-07-27

Hydrogels for localized radiotherapy

#101
20170209603
2017-07-27

Compositions targeting radiation-induced molecules and methods of use thereof

#102
20170202969
2017-07-20

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#103
20170143841
2017-05-25

HIGH MOLECULAR WEIGHT ZWITTERION-CONTAINING POLYMERS

#104
20170106105
2017-04-20

Nanostructures and applications thereof

#105
20170095580
2017-04-06

TCO conjugates and methods for delivery of therapeutic agents

#106
20170087258
2017-03-30

TCO conjugates and methods for delivery of therapeutic agents

#107
20170056518
2017-03-02

Pharmaceuticals in joint-linker configurations for treating pathological blood clots

#108
20160347679
2016-12-01

COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN

#109
20160235871
2016-08-18

Spect radionuclide-labeled trimeric cycle RGD peptide, preparation method thereof and imaging method thereof

#110
20160206754
2016-07-21

Molecular constructs for treating tumors

#111
20160193349
2016-07-07

Fucoidan nanogels and methods of their use and manufacture

#112
20160151518
2016-06-02

Radiolabelled material

#113
20160115252
2016-04-28

Labeled alginate conjugates for molecular imaging applications

#114
20160114061
2016-04-28

Kit for preparation of target radiopharmaceuticals and method of using it

#115
20160083485
2016-03-24

Therapeutic and imaging compositions and uses thereof

#116
20160067362
2016-03-10

HELICAL POLYCARBODIIMIDE POLYMERS AND ASSOCIATED IMAGING, DIAGNOSTIC, AND THERAPEUTIC METHODS

#117
20160038615
2016-02-11

Saccharide conjugates

#118
20160022763
2016-01-28

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

#119
20150374862
2015-12-31

Compositions and methods for detecting plectin-1 as a biomarker for cancer

#120
20150299066
2015-10-22

Radiofluorination method

#121
20150265731
2015-09-24

Method to improve the tumor diagnostic efficiency of multivalent ligands by regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for tumor targeting

#122
20150247008
2015-09-03

Chelating amphiphilic polymers

#123
20150165042
2015-06-18

Biodegradable compositions suitable for controlled release

#124
20150133645
2015-05-14

Labeled alginate conjugates for molecular imaging applications

#125
20150105602
2015-04-16

Polymeric radiation-sources

#126
20150025196
2015-01-22

Polyoxazoline polymers and methods for their preparation, conjugates of these polymers and medical uses thereof

#127
20150023875
2015-01-22

System for Targeted Delivery of Therapeutic Agents

#128
20150023872
2015-01-22

Homing agents

#129
20150004096
2015-01-01

Tumorspecific SPECT/MR(T1), SPECT/MR(T2) and SPECT/CT contrast agents

#130
20140377175
2014-12-25

Chemically-linked nanoparticles

#131
20140363376
2014-12-11

Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

#132
20140363371
2014-12-11

Telodendrimers with enhanced drug delivery

#133
20140350193
2014-11-27

Manganese comprising nanostructures

#134
20140314665
2014-10-23

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

#135
20140308205
2014-10-16

TRIFUNCTIONAL AND COMPLETELY CLEARABLE SPECIFIC TARGETING AGENTS AND METHODS THEREOF

#136
20140235790
2014-08-21

CARBOHYDRATE-BASED COMPOSITIONS AND METHODS FOR TARGETED DRUG DELIVERY

#137
20140234217
2014-08-21

REMOTE ASSEMBLY OF TARGETED NANOPARTICLES USING COMPLEMENTARY OLIGONUCLEOTIDE LINKERS

#138
20140219923
2014-08-07

Biodegradable compositions suitable for controlled release

#139
20140219917
2014-08-07

Oligosaccharide conjugates for targeting bacteria and uses related thereto

#140
20140199376
2014-07-17

Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

#141
20140186263
2014-07-03

MALEIMIDE-FUNCTIONALIZED GOLD NANOPARTICLES

#142
20140178300
2014-06-26

Theranostic imaging agents and methods of use

#143
20140134102
2014-05-15

Fucoidans as ligands for the diagnosis of degenerative pathologies

#144
20140023586
2014-01-23

Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran

#145
20130336888
2013-12-19

PSMA-targeted dendrimers

#146
20130323170
2013-12-05

Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals

#147
20130302243
2013-11-14

RADIOLABELED NANOSYSTEM, PROCESS FOR THE PREPARATION THEREOF AND ITS USE

#148
20130195758
2013-08-01

PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded

#149
20130171066
2013-07-04

POLYMERIC COMPLEMENTS TO A B-AMYLOID PEPTIDES

#150
20130156698
2013-06-20

Tissue targeting

#151
20130149242
2013-06-13

Labeled alginate conjugates for molecular imaging applications

#152
20130129621
2013-05-23

Integrin receptor antagonists and their methods of use

#153
20130101507
2013-04-25

Treatment of renal cell carcinoma

#154
20130095035
2013-04-18

Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis

#155
20130052127
2013-02-28

Composite body for antigen or drug delivery

#156
20130039852
2013-02-14

METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY

#157
20130011336
2013-01-10

IMAGING AGENTS OF FIBROTIC DISEASES

#158
20120259098
2012-10-11

Dendrimer compositions and methods of synthesis

#159
20120244070
2012-09-27

Fibronectin targeting contrast agent

#160
20120219499
2012-08-30

Compositions and methods for detecting plectin-1 as a biomarker for cancer

#161
20120213700
2012-08-23

Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran

#162
20120190793
2012-07-26

METHOD FOR THE PRODUCTION OF SCAFFOLDS FOR TISSUE ENGINEERING, COMPRISING THE USEOF AN ANCHORING UNIT, AND SCAFFOLD PRODUCED THEREWITH

#163
20120183475
2012-07-19

Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies

#164
20120171119
2012-07-05

Pegylated fluorobenzamide analogues, their synthesis and use in diagnostic imaging

#165
20120107236
2012-05-03

Liver-receptor imaging injection, dispensing method and pharmaceutical composition thereof

#166
20120093725
2012-04-19

Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies

#167
20120020881
2012-01-26

Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes

#168
20110293531
2011-12-01

Porphyrazine optical and dual optical/MR contrast and therapeutic agents

#169
20110270151
2011-11-03

IMAGE-GUIDED ENERGY DEPOSITION FOR TARGETED DRUG DELIVERY

#170
20110182989
2011-07-28

Peptide compositions and therapeutic uses thereof

#171
20110165074
2011-07-07

Chelating amphiphilic polymers

#172
20110118207
2011-05-19

MODIFIED HYDROXYPOLYMER CONJUGATES WITH BONE SEEKING AND TUMOR KILLING MOIETIES

#173
20110064651
2011-03-17

Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodies

#174
20100316715
2010-12-16

Chitosan composition

#175
20100267928
2010-10-21

ACTIVATABLE DIAGNOSTIC AND THERAPEUTIC COMPOUND

#176
20100266491
2010-10-21

System for targeted delivery of therapeutic agents

#177
20100254906
2010-10-07

Compositions based on polysaccharides grafted by polyamine or polysulphurised compounds

#178
20100196272
2010-08-05

COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN

#179
20100166695
2010-07-01

Multivalent Heterobifunctional Polymers And Methods Of Their Use

#180
20100135909
2010-06-03

DENDRIMERS AND METHODS OF MAKING AND USING THEREOF

#181
20100111866
2010-05-06

Receptor and antigen targeted prodrug

#182
20100111860
2010-05-06

Radioactive material containing chitosan for inhibiting cancer and preparation method thereof

#183
20100056776
2010-03-04

Method of preparing macromolecular contrast agents and uses thereof

#184
20090285757
2009-11-19

METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY

#185
20090264397
2009-10-22

Highly fluorinated oils and surfactants and methods of making and using same

#186
20080193377
2008-08-14

Radiolabeled Nanohybrids Targeting Solid Tumor Neovasculature and Method of Using Same

#187
20080153865
2008-06-26

WATER SOLUBLE PACLITAXEL DERIVATIVES

#188
20080124280
2008-05-29

Thyroid hormone analogs and methods of use

#189
20080031813
2008-02-07

Targeted combination immunotherapy of cancer and infectious diseases

#190
20070258907
2007-11-08

Polymer-coated paramagnetic particles

#191
20070253899
2007-11-01

Dual function polymer micelles

#192
20070155976
2007-07-05

Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals

#193
20070154398
2007-07-05

Block copolymers and nano micelles comprising the same

#194
20070154390
2007-07-05

Nuclear molecular imaging contrast agent

#195
20070134197
2007-06-14

Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination

#196
20070122346
2007-05-31

Conjugated macromolecules

#197
20060287220
2006-12-21

Water soluble paclitaxel prodrugs

#198
20060135404
2006-06-22

Water soluble paclitaxel derivatives

#199
20060111273
2006-05-25

Water soluble paclitaxel derivatives

#200
20060067881
2006-03-30

Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products

#201
20060002855
2006-01-05

Targeted combination immunotherapy of cancer and infectious diseases

#202
20050271585
2005-12-08

Extended conjugated polymers

#203
20050118105
2005-06-02

Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them

#204
20050002865
2005-01-06

Diagnostic/therapeutic agents